Skip to main content
D

DNA Group (T.R.) Ltd. — Investor Relations & Filings

Ticker · DNA ISIN · IL0011038523 TA Manufacturing
Open in API
Filings indexed 22 across all filing types
Latest filing 2026-01-25 Regulatory Filings
Country IL Israel
Listing TA DNA

About DNA Group (T.R.) Ltd.

http://www.dnas.co.il

DNA Group (T.R.) Ltd., formerly DNA Biomedical Solutions Ltd., is a company engaged in the biotechnology sector. Through its subsidiaries, it develops, manufactures, and markets patented ultrasound systems. The company also invests in biomedical companies and real estate.

Recent filings

Filing Released Lang Actions
Opening of Trading On Monday, January 26 2026-IC HOTELS B1
Regulatory Filings Classification · 1% confidence The document is a short announcement regarding the commencement of trading for a specific security (IC HOTELS B1) on a stock exchange. It does not contain financial statements, management reports, or proxy materials. As it is a brief regulatory notice regarding market activity that does not fit into specific categories like share buybacks or dividend announcements, it falls under the general regulatory filing category.
2026-01-25 English
Identifying Details of New Security -IC HOTELS B1
Share Issue/Capital Change Classification · 1% confidence The document is a short, formal notice identifying new securities (ISIN, Symbol, Security Name) for Israel Canada Hotels Ltd. It does not contain financial statements, management commentary, or meeting materials. It is a specific regulatory notification regarding the identification of securities, which fits best under the general regulatory filing category as it does not represent a share issuance event itself, but rather the identification details of existing or new securities.
2026-01-22 English
Following the completion of a Big Allotment and in light of the company's compliance with the conditions,the company's shares will continue trading in the main list; Sector Change
M&A Activity Classification · 1% confidence The document is a formal notice from the Tel Aviv Stock Exchange (TASE) regarding a change in sector classification and listing status for DNA GROUP (T.R.) LTD following a merger. It does not contain financial statements, proxy materials, or specific earnings data, but rather serves as a regulatory notification regarding exchange listing rules and sector categorization. As it is a general regulatory announcement from the exchange, it fits best under the RNS category.
2025-11-10 English
Zero Weight Cap Factor in TASE Indices
Regulatory Filings Classification · 1% confidence The document is a short notice from the TASE Indices Unit regarding a change in the weight cap factor for a specific security (DNA GROUP). It does not fit into financial reporting categories like 10-K or IR, nor is it a corporate action like a dividend or share buyback. As it is a regulatory/market announcement regarding index composition, it falls under the general regulatory filing category.
2025-11-10 English
Base price of 1 agora and unlimited price fluctuation
Delisting Announcement Classification · 1% confidence The document is a short, formal notice regarding trading parameters (base price and price fluctuation) for a specific security on a specific date. It does not contain financial statements, management reports, or proxy materials. It is a standard regulatory announcement regarding market operations, which fits best under the RNS (Regulatory Filings) category as it does not meet the criteria for specific corporate actions like dividends or share issues.
2025-11-10 English
Changes in the company's names and security names , effective as of f November 8, 2022
Regulatory Filings
2022-11-06 Hebrew (modern)

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.